IN DEPTH

Patient advisors: could they change the face of medtech trials?

New UK medical device regulation spells potential trial concerns for some IVD players

Point-of-Care diagnostics: A boon awaits under remote healthcare

MEDICAL DEVICES

“Greener” choices in inhalers garner increasing pharma, device company support

To address global climate change, some pharma and device makers have developed pressurized Metered Dose Inhalers.

REGULATION

UK med tech faces regulatory uncertainty post-Brexit

AI

How AI could help improve clinical trial diversity

Patient advisors: could they change the face of medtech trials?

New UK medical device regulation spells potential trial concerns for some IVD players

Point-of-Care diagnostics: A boon awaits under remote healthcare

05/23/2024 05:24:58
  • Home | Point-of-Care diagnostics
  • In this issue
  • Contents
  • Formacoat Company Insight
  • Formacoat
  • PAMA Manufacturing and Sterilization
  • Briefing
  • Industry news
  • The medical industry briefing
  • Covid-19 executive briefing by GlobalData
  • Sartorius
  • Picosun
  • Comment
  • No shortage of hurdles to overcome for implementation of IVDR in Europe for 2022
  • Orthopaedics trends: Tendon most mentioned term on Twitter Q4 2021
  • The growing elder population will continue to drive the global medical device ma
  • Sandvik Company Insight
  • Sandvik
  • In Depth
  • Patient advisors: could they change the face of medtech trials?
  • New UK medical device regulation spells potential trial concerns
  • Point-of-Care diagnostics: A boon awaits under remote healthcare
  • “Greener” choices in inhalers garner increasing pharma, device company support
  • mdi Consultants
  • In Data
  • Artificial intelligence hiring in the medical industry rose in January 2022
  • J&J top innovator at tail end of 2021
  • January 2022 saw a 33% drop in medical devices’ approval in the US
  • Events
  • Next Issue
03/01/2022 00:00:00